BS-Retinset-unknown

BS-Retinset-unknown refers to a drug candidate or series of candidates (specifically BS01 and BS02) within the pipeline of Retinset, a biotechnology company based in Barcelona, Spain. These candidates are developed using a proprietary topical ophthalmic delivery platform designed to transport therapeutic agents to specific ocular tissues via eye drops. While Retinset's BSL series (such as BSL01) is tailored for back-of-the-eye (retinal) conditions like diabetic retinopathy, the BS series targets the ocular surface and anterior segment. Specifically, BS01 is in development for Dry Eye Disease, and BS02 is being developed for Glaucoma. These candidates are typically small molecule formulations and are currently in the early stages of development, following the company's strategy of providing non-invasive, eco-friendly, and patent-protected ophthalmic treatments.